Fmoc-3-Bromo-L-Phenylalanine

Fmoc-3-Bromo-L-Phenylalanine is an Fmoc-protected L-phenylalanine derivative featuring a stereogenic center at the alpha carbon and a bromine substituent at the 3-position of the aromatic ring. The molecule combines a stable N-(9H-fluoren-9-ylmethoxycarbonyl) protecting group for compatibility with solid-phase peptide synthesis with a reactive aryl bromide that can participate in palladium-catalyzed cross-coupling chemistry. The side-chain aromatic system provides a defined hydrophobic and π-interaction motif, while the bromine enables downstream diversification into aryl amines, biaryl scaffolds, or heteroaryl analogs. As a chiral amino acid building block, it functions as a practical intermediate for constructing site-specifically functionalized peptides and for preparing halogenated aromatic fragments used in synthetic organic chemistry and applied chemical manufacturing.

1. Peptide Synthesis

Fmoc-3-Bromo-L-Phenylalanine enables peptide building block preparation for automated and manual peptide coupling workflows, where the Fmoc group supports controlled N-terminal deprotection and re-protection cycles. The alpha-amino acid framework with a protected amine and carboxyl functionality supports standard peptide bond formation chemistries, while the 3-bromo aromatic side chain remains intact through Fmoc manipulation steps. The aryl bromide can be retained for late-stage diversification after peptide assembly, supporting the construction of halogenated peptide analogs for structure-activity relationship studies. Downstream, this protected amino acid derivative can be used to generate site-specific aromatic variants that maintain stereochemical fidelity of the L-configuration during peptide construction.

2. Peptidomimetics And SAR

Fmoc-3-Bromo-L-Phenylalanine serves as a chiral aromatic intermediate for peptidomimetic construction and SAR-focused library synthesis where controlled side-chain functionalization is required. The brominated phenyl ring provides a handle for converting the aromatic substituent into alternative electronic and steric environments via cross-coupling, such as aryl-aryl bond formation or installation of additional substituents. The Fmoc-protected backbone allows incorporation into peptide-like scaffolds while preserving the defined stereocenter, supporting systematic comparison of analogs differing primarily at the 3-position of the phenyl ring. The resulting halogenated or further diversified peptide analogs can be used as chemical probes and scaffold variants in medicinal chemistry and biochemical research programs.

3. Side-Chain Functionalization

Fmoc-3-Bromo-L-Phenylalanine is suitable for side-chain functionalization strategies that leverage the aryl bromide as a synthetic linchpin for subsequent derivatization. The protected amine and carboxyl functionality allow the compound to be handled as an amino acid building block during coupling or intermediate preparation, while the bromine on the aromatic ring can undergo chemoselective transformations to introduce aryl, heteroaryl, or amino substituents. The stereochemical integrity of the L-phenylalanine core supports stereodefined products when the derivative is carried through multi-step sequences. Downstream synthetic utility includes preparation of functionalized aromatic amino acid fragments and peptide-ready intermediates for fine chemical synthesis and process chemistry intermediate development.

4. Chemical Biology Probes

Fmoc-3-Bromo-L-Phenylalanine can be applied to chemical biology research workflows that require incorporation of a handle for later conjugation or probe diversification. The Fmoc-protected amino acid format supports integration into peptides or peptide-like constructs, enabling site-specific placement of the aromatic bromide within a defined sequence context. The aryl bromide can be transformed into conjugation-ready motifs through cross-coupling to introduce tags, linkers, or recognition elements while maintaining the peptide's stereochemical and structural features. The resulting labeled or modified biomolecular scaffolds can be used to interrogate molecular interactions and binding-site preferences in biochemical studies.

5. Pharmaceutical Manufacturing Intermediates

Fmoc-3-Bromo-L-Phenylalanine is relevant to pharmaceutical manufacturing and specialty chemical production as a defined, stereochemically controlled intermediate for producing halogenated amino acid derivatives used in downstream synthesis. The Fmoc protecting group provides a robust N-protection strategy during controlled coupling and purification steps, while the 3-bromo aromatic functionality supports later conversion to substituted aromatic motifs that may be required for drug-like scaffold optimization. The compound's compatibility with peptide coupling chemistry makes it suitable for manufacturing routes that generate peptide intermediates or peptide-derived intermediates for further processing. Industrial relevance extends to fine chemical synthesis where halogenated aromatic amino acid building blocks support scalable preparation of diversified structures used in applied chemical development.

6. Process Chemistry Cross-Coupling

Fmoc-3-Bromo-L-Phenylalanine supports process chemistry and synthetic methodology development that exploits aryl bromide reactivity for cross-coupling-based diversification. The presence of the Fmoc-protected amino acid framework allows the compound to be processed as a stable chiral intermediate, while the brominated aromatic ring can be converted into biaryl or substituted aromatic products under palladium-catalyzed conditions. The defined L-stereocenter and protected amine/carboxyl pattern facilitate predictable downstream transformations, including conversion into peptide building blocks or further functionalized amino acid derivatives. The resulting products can serve as intermediate inputs for industrial fine chemical synthesis, enabling controlled generation of substituted aromatic motifs with amino acid-derived stereochemical information retained.

1. Implications of ligand-receptor binding kinetics on GLP-1R signalling

2. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy

3. Effect of Short-Term Desiccation, Recovery Time, and CAPA-PVK Neuropeptide on the Immune System of the Burying Beetle Nicrophorus vespilloides

4. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes

5. Uncarboxylated osteocalcin decreases insulin-stimulated glucose uptake without affecting insulin signaling and regulators of mitochondrial biogenesis in myotubes